Status:
COMPLETED
Spot Drug-Eluting Stenting for Long Coronary Stenoses
Lead Sponsor:
Cardiovascular Research Society, Greece
Conditions:
Angioplasty
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Most doctors who use the new drug-eluting stents for the treatment of long coronary narrowings tend to cover the full length of the lesion with long or multiple stents. The investigators hypothesized ...
Detailed Description
Coronary artery lesion length is an independent predictor of restenosis following coronary intervention and the deployment of multiple or long bare metal stents has been associated with an increased r...
Eligibility Criteria
Inclusion
- Consenting, consecutive patients with a de novo, native coronary artery lesion longer than 20 mm.
Exclusion
- Unprotected left main coronary artery stenosis,
- Left ventricular ejection fraction \<25%, OR
- Contraindication to aspirin or clopidogrel
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT00738556
Start Date
January 1 2003
End Date
September 1 2007
Last Update
January 29 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Athens Euroclinic
Athens, Attica, Greece, 11521
2
Athens Euroclinic
Athens, Greece